Central Pharmaceuticals (DHA:CENTRALPHL) Price-to-Tangible-Book : 4.03 (As of May. 01, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-01), Central Pharmaceuticals's share price is BDT23.70. Central Pharmaceuticals's Tangible Book per Share of Sep. 2022 for the quarter that ended in Sep. 2022 was BDT5.88. Hence, Central Pharmaceuticals's Price to Tangible Book Ratio of today is 4.03.

The historical rank and industry rank for Central Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

DHA:CENTRALPHL' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.85 Med: 1.92 Max: 17.45
Current: 4.24

During the past 11 years, Central Pharmaceuticals's highest Price to Tangible Book Ratio was 17.45. The lowest was 0.85. And the median was 1.92.

DHA:CENTRALPHL's Price-to-Tangible-Book is ranked worse than
73.2% of 873 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs DHA:CENTRALPHL: 4.24

A closely related ratio is called PB Ratio. As of today, Central Pharmaceuticals's share price is BDT23.70. Central Pharmaceuticals's Book Value per Sharefor the quarter that ended in Sep. 2022 was BDT5.88. Hence, Central Pharmaceuticals's P/B Ratio of today is 4.03.

Central Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Central Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Price-to-Tangible-Book Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

0.85

2.02

2.20

2.22

Central Pharmaceuticals Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.08	2.43	2.20	2.21	2.22

Competitive Comparison of Central Pharmaceuticals's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceuticals's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Price-to-Tangible-Book falls into.

Central Pharmaceuticals Price-to-Tangible-Book Calculation

Central Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2022 )
	=	23.70	/	5.882
	=	4.03

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Central Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals (DHA:CENTRALPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals (DHA:CENTRALPHL) Headlines

No Headlines